Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Stavudine/didanosine combination safe and effective in AIDS

April 10, 1997

Promising efficacy of combination therapy including Viracept for HIV

April 10, 1997

Pharmacia & Upjohn's Rescriptor cleared by FDA

April 8, 1997

Triangle Pharmaceuticals exercises option to acquire MKC-442

April 8, 1997

hCG potentially useful in fighting HIV

April 7, 1997

Anti-HIV agents from CNRS

April 7, 1997

GEM-91 associated with up to 90% decrease in cellular viremia in HIV-positive patients

April 4, 1997

Stavudine delays HIV progression in zidovudine-experienced patients

April 2, 1997

Procept's PRO-2000 covered by U.S. patent

April 2, 1997

Update on NABI's HIV-IG clinical trials

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...